Media

November 28, 2025: French Tech : Maat Pharma, un anticancer issu du microbiote – BFM Business (French Only)

Date : November 28, 2025

To listen to the interview, click here!

SFGM-TC 2025

December 8, 2025: MaaT Pharma Presents Pivotal ARES Phase 3 Results for MaaT013 (Xervyteg®) in Acute GvHD at ASH 2025 Annual Congress and Announces 54% 1-Year Overall Survival